Ekundayo B, Arullampalam P, Gerber C, Hammerli A, Guichard S, Boukenna M
Nat Commun. 2025; 16(1):833.
PMID: 39828793
PMC: 11743598.
DOI: 10.1038/s41467-025-56131-2.
Toth B, Jiang Y, Szollosi A, Zhang Z, Csanady L
Proc Natl Acad Sci U S A. 2024; 121(46):e2415548121.
PMID: 39514307
PMC: 11573590.
DOI: 10.1073/pnas.2415548121.
Gandini M, Zamponi G
Int J Mol Sci. 2024; 25(19).
PMID: 39408620
PMC: 11476983.
DOI: 10.3390/ijms251910284.
Celik M, Cicek D, Demir B, Kuloglu T, Artas G, Hancer S
Arch Dermatol Res. 2024; 316(10):675.
PMID: 39400728
DOI: 10.1007/s00403-024-03417-y.
Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F
Signal Transduct Target Ther. 2024; 9(1):271.
PMID: 39396974
PMC: 11486532.
DOI: 10.1038/s41392-024-01969-z.
Melastatin subfamily Transient Receptor Potential channels support spermatogenesis in planarian flatworms.
Curry H, Huynh R, Rouhana L
bioRxiv. 2024; .
PMID: 39282438
PMC: 11398416.
DOI: 10.1101/2024.09.01.610670.
Finely ordered intracellular domain harbors an allosteric site to modulate physiopathological function of P2X3 receptors.
Lin Y, Lu Y, Li C, Ma X, Shao M, Gao Y
Nat Commun. 2024; 15(1):7652.
PMID: 39227563
PMC: 11372093.
DOI: 10.1038/s41467-024-51815-7.
NOX2-TRPM2 coupling promotes Zn inhibition of complex III to exacerbate ROS production in a cellular model of Parkinson's disease.
Alahmad M, Isbea H, Shitaw E, Li F, Sivaprasadarao A
Sci Rep. 2024; 14(1):18431.
PMID: 39117781
PMC: 11310326.
DOI: 10.1038/s41598-024-66630-9.
Bidirectional regulation mechanism of TRPM2 channel: role in oxidative stress, inflammation and ischemia-reperfusion injury.
Huang P, Qu C, Rao Z, Wu D, Zhao J
Front Immunol. 2024; 15:1391355.
PMID: 39007141
PMC: 11239348.
DOI: 10.3389/fimmu.2024.1391355.
Structural dynamics at cytosolic interprotomer interfaces control gating of a mammalian TRPM5 channel.
Karuppan S, Schrag L, Pastrano C, Jara-Oseguera A, Zubcevic L
Proc Natl Acad Sci U S A. 2024; 121(27):e2403333121.
PMID: 38923985
PMC: 11228501.
DOI: 10.1073/pnas.2403333121.
Coupling enzymatic activity and gating in an ancient TRPM chanzyme and its molecular evolution.
Huang Y, Kumar S, Lee J, Lu W, Du J
Nat Struct Mol Biol. 2024; 31(10):1509-1521.
PMID: 38773335
PMC: 11479946.
DOI: 10.1038/s41594-024-01316-4.
Thermal gradient ring for analysis of temperature-dependent behaviors involving TRP channels in mice.
Ujisawa T, Lei J, Kashio M, Tominaga M
J Physiol Sci. 2024; 74(1):9.
PMID: 38331738
PMC: 10851596.
DOI: 10.1186/s12576-024-00903-w.
2'-deoxy-ADPR activates human TRPM2 faster than ADPR and thereby induces higher currents at physiological Ca concentrations.
Pick J, Sander S, Etzold S, Rosche A, Tidow H, Guse A
Front Immunol. 2024; 15:1294357.
PMID: 38318185
PMC: 10838996.
DOI: 10.3389/fimmu.2024.1294357.
TRP Channels in Stroke.
Zong P, Li C, Feng J, Cicchetti M, Yue L
Neurosci Bull. 2023; 40(8):1141-1159.
PMID: 37995056
PMC: 11306852.
DOI: 10.1007/s12264-023-01151-5.
Interaction of Calmodulin with TRPM: An Initiator of Channel Modulation.
Vydra Bousova K, Zouharova M, Jiraskova K, Vetyskova V
Int J Mol Sci. 2023; 24(20).
PMID: 37894842
PMC: 10607381.
DOI: 10.3390/ijms242015162.
TRPM channels in health and disease.
Chubanov V, Kottgen M, Touyz R, Gudermann T
Nat Rev Nephrol. 2023; 20(3):175-187.
PMID: 37853091
DOI: 10.1038/s41581-023-00777-y.
Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7.
Okada Y, Numata T, Sabirov R, Kashio M, Merzlyak P, Sato-Numata K
Front Cell Dev Biol. 2023; 11:1246955.
PMID: 37842082
PMC: 10576435.
DOI: 10.3389/fcell.2023.1246955.
TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy.
Yu B, Jin L, Yao X, Zhang Y, Zhang G, Wang F
Theranostics. 2023; 13(13):4356-4375.
PMID: 37649595
PMC: 10465213.
DOI: 10.7150/thno.84655.
TRPM2: bridging calcium and ROS signaling pathways-implications for human diseases.
Maliougina M, Hiani Y
Front Physiol. 2023; 14:1217828.
PMID: 37576339
PMC: 10412822.
DOI: 10.3389/fphys.2023.1217828.
Identification of TRPM2 as a Potential Therapeutic Target Associated with Immune Infiltration: A Comprehensive Pan-Cancer Analysis and Experimental Verification in Ovarian Cancer.
Zheng D, Long S, Xi M
Int J Mol Sci. 2023; 24(15).
PMID: 37569287
PMC: 10418504.
DOI: 10.3390/ijms241511912.